Amar D, Fleisher M, Pantuck CB, Shamoon H, Zhang H, Roistacher N, Leung DHY, Ginsburg I, Smiley RM (1998). Persistent alterations of the autonomic nervous system after noncardiac surgery. Anesthesiology 89:30-42. [PubMed Abstract]
Bajorin DF, McCaffrey JA, Hilton S, Mazumdar M, Kelly WK, Scher HI, Spicer J, Herr H, Higgins G (1998). Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin - a phase II trial. Journal of Clinical Oncology. 16:2722-2727. [PubMed Abstract]
Bajorin DF, Mazumdar M, Meyers M, Motzer RJ, Vlamis V, Lin P, Bosl GJ (1998). Metastatic germ cell tumors: Modeling for response to chemotherapy. Journal of Clinical Oncology. 16:707-715. [PubMed Abstract]
Barakat RR, Almadrones L, Venkatraman ES, Aghajanian C, Brown C, Shapiro F, Curtin JP, Spriggs D (1998). A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II-IV epithelial ovarian-cancer following negative surgical assessment. Gynecologic Oncology 69:17-22. [PubMed Abstract]
Barendswaard EC, Scott AM, Divgi CR, Williams Jr C, Coplan K, Riedel E, Yao TJ, Gansow OA, Finn RD, Larson SM, Old LJ, Welt S. Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice. International Journal of Oncology 1998;12:45-53. [PubMed Abstract]
Begg CB: Discussion remarks on meta-analysis. In: Epidemiological Practices in Research on Small Effects. (1998) Eds. Hoffmeister M, Szklo M, Thamm M, Springer-Verlag. Berlin. pp 119-120.
Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery (with editorial). Journal of the American Medical Association. 1998; 280:1747-1751. [PubMed Abstract]
Begg CB, Satagopan JM, Berwick M: A new strategy for evaluating the impact of epidemiologic risk factors for cancer with application to melanoma. Journal of the American Stat Association 1998;93:415-426.
Blair SL, Lewis JJ, Leung D, Woodruff J, Brennan MF. (1998) Multifocal extremity sarcoma: an uncommon and controversial entity. Annals of Surgical Oncology 5:37-40. [PubMed Abstract]
Brooks AD, Heslin MJ, Leung DHY, Lewis JJ, Brennan MF (1998) Superficial extremity soft-tissue sarcoma - an analysis of prognostic factors. Annals of Surgical Oncology 5:41-47. [PubMed Abstract]
Casper ES, Waltzman RJ, Schwartz GK, Sugarman A, Pfister D, Ilson D, Woodruff J, Leung D, Bertino JR (1998). Phase II trial of paclitaxel in patients with soft tissue sarcoma. Cancer Investigation 16:442-446. [PubMed Abstract]
Chang VT, Thaler HT, Polyak TA, Kornblith AB, Lepore JM, Portenoy RK. (1998) Quality-of-life and survival: the role of multidimensional symptom assessment. Cancer 83:173-179. [PubMed Abstract]
Chervenak FA, Skupski DW, Romero R, Myers MK, Smithley M, Rosenwaks Z, Thaler HT. (1998) How accurate is fetal biometry in the assessment of fetal age. American Journal of Obstetrics 178:678-687. [PubMed Abstract]
Clark TB, Kemeny NE, Conti JA, Huang Y, Andre AM, Stockman J. (1998) Phase II trial of docetaxel (taxotere (R) for untreated advanced colorectal carcinoma. Cancer Inv; 16:314-318. [PubMed Abstract]
Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI. (1998) Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. Journal of the National Cancer Institute, 90:1284-1291. [PubMed Abstract]
De Craen AJM, Vickers AJ, Tijssen JGP, Kleijnen J. (1998) The number-needed-to-treat and placebo-controlled trials. Lancet; 351:310. [PubMed Abstract]
Ezzo J, Berman BM, Vickers AJ, Linde K. Complementary Medicine and the Cochrane Collaboration. Journal of the American Medical Association 1998;280:1628-30. [PubMed Abstract]
Fokianos K, Kedem B, Qin J, Haferman JL and Short DA. (1998) On combining instruments. Journal of Applied Meterorology 37:220-226.
Heath, S.C. (1998) Generating consistent genotype configurations for multi-allelic loci and large complex pedigrees. Human Heredity, 48:1-11. [PubMed Abstract]
Hudis C, Riccio L, Seidman A, Baselga J, Currie V, Fennelly D, Gilewski T, Lebwohl D, Moynahan M, Raptis G, Surbone A, Sklarin N, Yao TJ, Keefe D, Norton L. (1998) Lack of increased cardiac toxicity with sequential doxorubicin and paclitaxel. Cancer Investigation. 16:67-71. [PubMed Abstract]
Husain A, He G, Venkatraman ES, Spriggs DR. (1998) BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Research 58:1120-3. [PubMed Abstract]
Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen. (1998) Phase II trial of paclitaxel fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. Journal of Clinical Oncology. 16:1826-1834. [PubMed Abstract]
Imbriaco M, Larson SM, Yeung HW, Mawlawi OR, Erdi Y, Venkatraman ES, Scher HI. (1998) A new parameter for measuring metastatic bone involvement by prostate-cancer - the bone scan index. Clinical Cancer Research 4:1765-1772. [PubMed Abstract]
Jenkins M, Vickers AJ. (1998) Unreliability of IgE / IgG4 antibody testing as a diagnostic tool in food intolerance. Clinical and Experimental Allergy 28:1526-9. [PubMed Abstract]
Korst RJ, Rush VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, Ginsberg RJ: (1998) Proposed revision of the staging classification for esophageal cancer. Journal of Thoracic Surgery. 115:660-669. [PubMed Abstract]
Kourea HP, Bilsky MH, Leung DHY, Lewis JJ, Woodruff JM (1998). Subdiaphragmatic and intrathoracic paraspinal malignant peripheral-nerve sheath tumors - A clinicopathological study of 25 patients and 26 tumors. Cancer 82:2191-2203. [PubMed Abstract]
Kushner BH, Heller G, Cheung NK, Wollner N, Kramer K, Bajorin D, Polyak T, Meyers PA. (1998) High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. Journal of Clinical Oncology. 16:3016-3020. [PubMed Abstract]
Landolfi JC, Thaler HT, Deangelis LR. (1998) Adult brain-stem gliomas. Neurology 51:1136-1139. [PubMed Abstract]
Leung, DHY, Wang Y. (1998) Bias reduction using stochastic approximation. Australian & New Zealand Journal of Statistics 40:43-52.
Lewis JJ, Leung D, Woodruff JM, Brennan MF (1998). Retroperitoneal soft-tissue sarcoma - analysis of 500 patients treated and followed at a single institution. Ann Surg 228:355-363. [PubMed Abstract]
Lewis JJ, Leung D.H.Y., Casper ES, Woodruff J, Hajdu SI, Brennan MF (1998) Multifactorial analysis of long-term follow-up (>5 year) of primary extremity sarcoma. Annals of Surgery 228:355-365.
Li G, Qin J. (1998) Semiparametric likelihood based inferences for biased and truncated data when total sample size is known. Journal of the Royal Statistics Society 60:243-2548.
McCaffrey JA, Dodd PM, Herr H, Vlamis V, Mazumdar M, Higgins G, Scher HI, Bajorin DF (1998). Anatomic site of primary transitional-cell carcinoma does not affect probability of response to M-VAC or survival. Journal of Urology 159:628.
Melchart D, Linde K, Fischer P, Berman B, White A, Vickers AJ, Weinschütz T, Allais G. (1998) Acupuncture for chronic headache. (Cochrane Protocol) In: The Cochrane Library, Issue 3. Oxford: Update Software.
Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VVS, Mazumdar M, Bosl GJ, Chaganti RSK, Reuter VE (1998). Teratoma with malignant transformation - diverse malignant histologies arising in men with germ-cell tumors. Journal of Urology 159:133-138. [PubMed Abstract]
Nanus DM, Bogenrieder T, Papandreou CN, Finstad CL, Lee A, Vlamis V, Motzer RJ, Bander NH, Albino AP, Reuter VE. (1998) Aminopeptidase A expression and enzymatic activity in primary human renal cancers. International Journal of Oncology 13:261-267. [PubMed Abstract]
Newman KD, Black T, Heller G, Azizkhan RG, Holcomb GW, Sklar C, Vlamis V, Haase GM, LaQuaglia MP. (1998) Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Annals of Surgery 227:533-541. [PubMed Abstract]
Pasche B, Luo Y, Rao PH, Nimer SD, Dmitrovsky E, Caron P, Luzzatto L, Offit K, Cordon-Cardo C, Renault B, Satagopan JM, Murty VVS, Massague J (1998): Type I TGF-ß receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Research 58:2727-2732. [PubMed Abstract]
Pisters PW, Feig BW, Leung DH, Brennan MF (1998). New developments in soft tissue sarcoma. [Review] Cancer Treatment and Research 90:91-107.
Qin J. (1998) Inferences for case-control and semiparametric two-sample density ratio models. Biometrika 85:619-630.
Qin J. (1998) Semiparametric likelihood based method for goodness of fit test and estimation in upgraded mixture models. Scandinavian Journal of Statistics 25:681-691.
Redston M, Nathanson KC, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, Gallinger S, Kaback M, King MC, Woodage T, Brody LC, Godwin A, Warner E, Weber B, Foulkes W, Offit K (1998): The APC I1307K allele and breast cancer risk (Letter). Nature Genetics 20:13-14. [PubMed Abstract]
Saenz NC, Heslin MJ, Adsay V, Lewis JJ, Leung DH, LaQuaglia MP, Brennan MF (1998) Neurovascularity and clinical outcome in high-grade extremity soft-tissue sarcomas. Annals of Surgical Oncology 5:48-53. [PubMed Abstract]
Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. (1998) Clinical stage I testis cancer - long-term outcome of patients on surveillance. Journal of Urology 159:855-858. [PubMed Abstract]
Vickers AJ, Fisher P, Smith C, Wyllie SE, Rees RW. (1998) Homoeopathic Arnica 30x is ineffective for muscle soreness after long-distance running: a randomised, double-blind, placebo-controlled trial. Clinical Journal of Pain 14:227-31. [PubMed Abstract]
Vickers AJ, Harland R, Goyal N, Rees R. (1998) Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clinical Trials 19:159-66.
Vickers AJ, Rees RW, Robin A. (1998) Advice given by health food shops: is it clinically safe? Journal of the Royal College of Physicians of London 32:426-8. [PubMed Abstract]
Vickers AJ. (1998) For pluralism in medicine (editorial). Complementary Therapies in Medicine 6:169-71.
Vickers AJ. (1998) Evidence-based medicine and complementary medicine. Evidence-Based Medicine 3:168-9.
Vickers AJ. (1998) Against individualistic medicine (editorial). Complementary Therapies in Medicine 6:61-3.
Vickers AJ. (1998) Complementary medicine: a research perspective (book review). Complementary Therapies in Medicine 6:55-6.
Vickers AJ. (1998) Against philosophy (editorial). Complementary Therapies in Medicine 6:1-3.
Vickers AJ. (1998) Against mind-body medicine (editorial). Complementary Therapies in Medicine 6:111-4
Vickers AJ. (1998) Bibliometric analysis of randomised controlled trials in complementary medicine. Complementary Therapies in Medicine 6:185-9.
Wang Y, Leung DHY. (1998) An optimal sequential design for screening trials. Biometrics 54:245-252.
Wickens JC, Whelan RL, Allendorf JD, Donahue J, Buxton E, McKee A, Panageas K, Gleason N, Lee S, Bessler M. (1998) Wound tensile strength and contraction rate are not affected by laparotomy or pneumoperitoneum. Surgical Endoscopy 12:1166-1170. [PubMed Abstract]
Yang K, Edelmann W, Fan K, Lau K, Leung D, Newmark H, Kucherlapati R, Lipkin M (1998). Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis. Cancer Research 58:5713-5717. [PubMed Abstract]
Yao TJ, Venkatraman ES. (1998) Optimal two-stage design for a series of pilot trials of new agents. Biometrics 54:1183-1189. [PubMed Abstract]
Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatraman ES, Reuter VE, Fair WR, Ling CC, Fuks Z. (1998) Dose-escalation with 3-dimensional conformal radiation therapy affects the outcome in prostate cancer. Internation Journal of Radiation Oncology. 41:491-500. [PubMed Abstract]
Zelefsky MJ, Fuks Z, Wolfe T, Kutcher GJ, Burma C, Ling CC, Venkatraman ES, Leibel SA. (1998) Locally advanced prostatic-cancer - long-term toxicity outcome after 3-dimensional conformal radiation-therapy - a dose-escalation study. Radiology 209:169-174. [PubMed Abstract]
